Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinoma

BACKGROUND: Treatments based on the inhibition of pivotal signals of cancer stem cells (CSCs) are on a promising track. Recent studies have shown that targeting CSCs with broader immune‐based therapeutic methods, for example, the anti‐CD47 treatment, may serve as a more potent strategy for eliminati...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jian‐Hua, Huang, Shu‐Ting, Zhang, Lan, Liu, Zi‐Gang, Liang, Rong‐Xin, Jiang, Sen‐Wei, Jiang, Yi‐Nan, Yu, Xing‐Juan, Jiang, Yu‐Chuan, Li, Xi‐Zhao, Zhang, Pei‐Fen, Wen, Zhe‐Sheng, Zheng, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Cancer Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434369/
https://www.ncbi.nlm.nih.gov/pubmed/30741466
http://dx.doi.org/10.1002/cam4.1894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434369/
https://www.ncbi.nlm.nih.gov/pubmed/30741466
http://dx.doi.org/10.1002/cam4.1894

Ejemplares similares